Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it

Pharmacopsychiatry

Volumn 33, Issue 1, 2000, Pages 8-13

  Kallner, G ^b   Lindelius, R ^a   Petterson, Ulla ^a   Stockman, O ^a   Tham, A ^a  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SUICIDE; TREATMENT OUTCOME;

EID: 0033972116     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7965     Document Type: Article

References (24)

1. 1 Ahrens B, Müller-Oerlinghausen B, Schou M, Wolf T, Alda M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Vestergaard P, Wolf R, Möller HJ: Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord 1995; 33: 67-75
2. 2 Alström CH: Mortality in mental hospitals with especial regard to tuberculosis. Acta Psychiatr Scand (Kbh) 1942; 24: 40-44
3. 3 American Psychiatric Association: Diagnostic and statistical manual of mental disorders. Third edition, revised, (DSM-III-R). Washington D.C. American Psychiatric Association 1987
4. 4 Causeman B, Müller-Oerlinghausen B: Does lithium prevent suicides and suicide attempts? In: Birch NY (ed): Lithium: Inorganic pharmacology and psychiatric use. Oxford. IRL Press 1988: 23-24
5. 5 Coppen A: Depression as a lethal disease: Prevention strategies. J Clin Psychiatry 1994; 55: 37-54
6. 6 Kallner G, Petterson U: Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. Acta Psychiatr Scand 1995; 91: 45-51
7. 7 Kreitman N: Suicide, age and marital status. Psychol Med 1988; 18: 121-128
8. 8 Lindberg S, Agren G: Mortality among male and female hospitalized alcoholics in Stockholm 1962-1983. Br J Addict 1988; 83: 1193-1200
9. 9 Lindelius R: A study in schizofrenia. Acta Psychiatr Scand 1970; 216: 56
10. 10 Lundqvist G: Prognosis and cause of manic-depressive psychoses. Acta Psychiatr et Neurol Scand 1945; 35: 1-96
11. 11 Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, Simhandl C, Thau K, Volk J, Wolf R, Wolf T: The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 1992a; 86: 218-222
12. 12 Müller-Oerlinghausen B, Müser-Causemann B, Volk J: Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992b; 25: 261-270
13. 13 Müller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Lenz G, Simhandl C, Thau K, Wolf R: Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-Treated Patients (IGSLI). Acta Psychiatr Scand 1994; 90: 295-297
14. 14 Müller-Oerlinghausen B, Wolf T, Ahrens B, Glaenz T, Schou M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Vestergaard P, Wolf R: Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Group for the Study of Lithium-Treated Patients (IGSLI). Acta Psychiatr Scand 1996; 94: 344-347
15. 15 Nilsson A, Axelsson R: Lithium discontinuers. I. Clinical characteristics and outcome. Acta Psychiatr Scand 1990; 82: 433-438
16. 16 Nilsson A: Mortality in recurrent mood disorders during periods on and off lithium. Pharmacopsychiat 1995; 28: 8-13
17. 17 Norton B, Walley LJ: Mortality of a lithium-treated population. Br J Psychiatry 1984; 145: 277-282
18. 18 Petterson U: Manic-depressive illness. A clinical, social and genetic study. Acta Psychiatr Scand 1977; 269: 1-93
19. 19 Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW: Depression, psychotropic medication and risk of myocardial infarction. Circulation 1996; 94: 3123-3129
20. 20 Schou M: Forty years of lithium treatment. Arch Gen Psychiatry 1997; 54: 9-13
21. 21 Schou M: Has the time come to abandon prophylactic lithium treatment? A review for clinicians. Pharmacopsychiat 1998; 31: 210-215
22. 22 Sharma R, Markar HR: Mortality in affective disorder. J Affect Disord 1994; 31: 91-96
23. 23 Vestergaard P, Aagaard J: Five year mortality in lithium-treated manic-depressive patients. J Affect Disord 1991; 21: 33-38
24. 24 Winokur G, Coryell W, Endicott J, Akiskal H: Further distinction between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). Am J Psychiatry 1993; 150: 1176-1181